Overview

Immediate Therapeutic Effects of Diquafosol and Rebamipide in Dry Eye Disease

Status:
COMPLETED
Trial end date:
2024-08-30
Target enrollment:
Participant gender:
Summary
This study compares the immediate therapeutic and mucin-secreting effects 30 minutes after instillation of 3% diquafosol and 2% rebamipide in dry eye disease.
Phase:
PHASE4
Details
Lead Sponsor:
Korea University Anam Hospital
Collaborator:
Kukje Pharma
Treatments:
diquafosol
rebamipide